RxDoctor Payments Data

Vadim Guy

Optometrist · Rochester, NYNPI 1205119120

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Clerio Vision, Inc at 48.8% of the total. Reporting peaked in 2022 at $15,306 and has fallen 93.2% since, to $1,040 in 2025. Among optometrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,014in general payments, 2019–2025

Across 112 payments — averaging $276.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Clerio Vision, Inc$15K
  • Visioneering Technologies, Inc.$11K
  • Coopervision Inc.$1K
  • Johnson & Johnson Vision Care, Inc.$828
  • Sight Sciences, Inc.$568
  • Bausch & Lomb Americas Inc.$540
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$15,16549%
  • Speaking & faculty fees$11,13036%
  • Food & beverage$4,68115%
  • Gifts$390%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,014 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.

See all optometrist providers in New York

Medicare billing

Part B allowed, 2024
$2,303
Medicare patients
15
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost36$404

Paid to pharmacies, not to this prescriber.

Other optometrist in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →